These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15528450)

  • 1. Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters.
    Bardin L; Assié MB; Pélissou M; Royer-Urios I; Newman-Tancredi A; Ribet JP; Sautel F; Koek W; Colpaert FC
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1034-42. PubMed ID: 15528450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist.
    Deseure K; Bréand S; Colpaert FC
    Eur J Pharmacol; 2007 Jul; 568(1-3):134-41. PubMed ID: 17512927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning.
    Colpaert FC; Deseure K; Stinus L; Adriaensen H
    J Pharmacol Exp Ther; 2006 Feb; 316(2):892-9. PubMed ID: 16254131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous administration of the 5-hydroxytryptamine1A agonist (3-Chloro-4-fluoro-phenyl)-[4-fluoro-4-[[(5-methyl-pyridin-2-ylmethyl) -amino]-methyl]piperidin-1-yl]-methadone (F 13640) attenuates allodynia-like behavior in a rat model of trigeminal neuropathic pain.
    Deseure K; Koek W; Adriaensen H; Colpaert FC
    J Pharmacol Exp Ther; 2003 Aug; 306(2):505-14. PubMed ID: 12730352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
    Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C; Kleven M
    J Med Chem; 1999 May; 42(9):1648-60. PubMed ID: 10229633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-efficacy 5-HT1A receptor activation causes a curative-like action on allodynia in rats with spinal cord injury.
    Colpaert FC; Wu WP; Hao JX; Royer I; Sautel F; Wiesenfeld-Hallin Z; Xu XJ
    Eur J Pharmacol; 2004 Aug; 497(1):29-33. PubMed ID: 15321732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology.
    Cussac D; Palmier C; Finana F; De Vries L; Tardif S; Léger C; Bernois S; Heusler P
    J Pharmacol Exp Ther; 2009 Oct; 331(1):222-33. PubMed ID: 19605522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain.
    Assié MB; Ravailhe V; Faucillon V; Newman-Tancredi A
    J Pharmacol Exp Ther; 2005 Oct; 315(1):265-72. PubMed ID: 15987834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the high-efficacy 5-HT1A receptor agonist, F 13640 in the formalin pain model: a c-Fos study.
    Buritova J; Larrue S; Aliaga M; Besson JM; Colpaert F
    Eur J Pharmacol; 2005 May; 514(2-3):121-30. PubMed ID: 15910798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
    Liu FY; Xing GG; Qu XX; Xu IS; Han JS; Wan Y
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1046-53. PubMed ID: 17329553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats.
    Jeong CY; Choi JI; Yoon MH
    Eur J Pharmacol; 2004 Oct; 502(3):205-11. PubMed ID: 15476746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatigue of cholestasis and the serotoninergic neurotransmitter system in the rat.
    Celik T; Gören MZ; Cinar K; Gürdal H; Onder FO; Tan A; Terzioğlu B; Bozdayi AM; Bozkaya H; Uzunalimoğlu O; Yurdaydin C
    Hepatology; 2005 Apr; 41(4):731-7. PubMed ID: 15726642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel analgesic and high-efficacy 5-HT1A receptor agonist F 13640 inhibits nociceptive responses, wind-up, and after-discharges in spinal neurons and withdrawal reflexes.
    You HJ; Colpaert FC; Arendt-Nielsen L
    Exp Neurol; 2005 Jan; 191(1):174-83. PubMed ID: 15589524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo.
    Carrasco GA; Van de Kar LD; Jia C; Xu H; Chen Z; Chadda R; Garcia F; Muma NA; Battaglia G
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1078-86. PubMed ID: 17159160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist.
    Piper BJ; Vu HL; Safain MG; Oliver AJ; Meyer JS
    J Pharmacol Exp Ther; 2006 May; 317(2):838-49. PubMed ID: 16434566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo.
    Guenther U; Manzke T; Wrigge H; Dutschmann M; Zinserling J; Putensen C; Hoeft A
    Anesth Analg; 2009 Apr; 108(4):1169-76. PubMed ID: 19299781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance and inverse tolerance to the hyperalgesic and analgesic actions, respectively, of the novel analgesic, F 13640.
    Bruins Slot LA; Koek W; Tarayre JP; Colpaert FC
    Eur J Pharmacol; 2003 Apr; 466(3):271-9. PubMed ID: 12694810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies.
    Barrondo S; Sallés J
    Neuropharmacology; 2009 Feb; 56(2):455-62. PubMed ID: 18951909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system.
    Khawaja XZ; Smith DL; Nawoschik SP; Zhang J; Dunlop J; Dilks DW; Olsen M; Schechter LE
    J Neurochem; 2006 Jul; 98(1):134-45. PubMed ID: 16805803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties.
    Schechter LE; Smith DL; Rosenzweig-Lipson S; Sukoff SJ; Dawson LA; Marquis K; Jones D; Piesla M; Andree T; Nawoschik S; Harder JA; Womack MD; Buccafusco J; Terry AV; Hoebel B; Rada P; Kelly M; Abou-Gharbia M; Barrett JE; Childers W
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1274-89. PubMed ID: 15951399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.